CD19 and breast carcinoma: Indeed, Tao and colleagues showed that CD19+ IL10− B cells derived from tumor-draining lymph nodes (and in vitro activated) express FASL which triggers the apoptotic signal in 4T1 murine breast cancer cells expressing FAS [6].